What Impacts Adult Vaccination?
Drug Topics
OCTOBER 21, 2022
Adult vaccine uptake lags and understanding the reasons could be important.
Sat.Oct 15, 2022 - Fri.Oct 21, 2022
529 
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
5 impactful drug trial failures from the last year
PharmaVoice
OCTOBER 19, 2022
Major recent trial flops and what they mean for companies, patients and the industry.
Vitamin D Shows Promise in Lowering Risk of Cardiovascular Disease
Pharmacy Times
OCTOBER 18, 2022
A new review identified vitamin D as an important factor in maintaining endothelial progenitor cell health and function, which can impact risk of developing cardiovascular disease.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug-related Deaths in Older Adults on the Rise
Drug Topics
OCTOBER 17, 2022
Two reports show that drug-related deaths are skyrocketing among people 65 years and older.
Three ways 340B is failing vulnerable patients
PhRMA
OCTOBER 20, 2022
The 340B Drug Pricing Program is 30 years old this year, but as The New York Times recently spelled out , the program has become a profit engine for large health systems over the years instead of a program that helps vulnerable, low-income patients. Powerful hospitals have twisted the program to boost their bottom line.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Cancer Vaccine May be Effective for Melanoma Patients
Pharmacy Times
OCTOBER 17, 2022
A researcher suggests that novel immune modulating cancer therapies like cancer vaccines can be more effective and safer alternative to previous cancer immunotherapies.
Vaccine Hesitancy Trends from 2019 to 2022 Evaluated
Drug Topics
OCTOBER 21, 2022
As vaccine hesitancy grows, fewer children are receiving routine childhood vaccines.
Don’t take anti-innovation, activist funded academics at their word
PhRMA
OCTOBER 18, 2022
It’s disappointing to see yet more studies published by activist-funded industry critics that fail to recognize the nature of competition in the biopharmaceutical market and use cherry-picked data to draw misleading conclusions.
A new class of drugs with ‘huge’ potential in the fight against challenging breast cancers
PharmaVoice
OCTOBER 18, 2022
Drug developers have been making headway in treating the most difficult and deadly forms of breast cancer.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Artificial Intelligence is Changing the Face of Pharmacovigilance
Pharmacy Times
OCTOBER 17, 2022
Pharmaceutical companies are looking into AI as the new method to not only reduce research and development costs, but also prevent costly errors.
Over 1 Million Adults Rationed Insulin in 2021
Drug Topics
OCTOBER 18, 2022
Study examines patient action that ‘is frequently harmful, and sometimes deadly.’.
Many seniors are paying more for Part D medicines than their insurer
PhRMA
OCTOBER 18, 2022
For seniors who rely on Medicare Part D, the out-of-pocket costs for medicines can sometimes be a barrier. Insurers and pharmacy benefit managers (PBMs) continue to shift more and more costs to patients. And a new analysis from the Medicare Payment Advisory Commission (MedPAC) shows why this is a problem that must be addressed.
J&J reveals just how much economic turbulence is affecting Big Pharma
PharmaVoice
OCTOBER 20, 2022
The healthcare giant showed pharmaceutical gains, but that's no thanks to the economic environment of persistent inflation and a strong U.S. dollar.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
12 Things Pharmacy Students Can Do to Become Leaders
Pharmacy Times
OCTOBER 21, 2022
Small choices during pharmacy school can help students on the path to becoming leaders in the field.
Receipt of Routine Vaccines May Be Predictive of COVID-19 Vaccination Status
Drug Topics
OCTOBER 20, 2022
Adults who receive influenza and pneumococcal vaccines may be more likely to receive COVID-19 vaccines and boosters.
Biosimilar uptake is increasing and so are health savings
PhRMA
OCTOBER 17, 2022
There has been a lot of talk recently about the biosimilars marketplace and what role biosimilars play in reducing health care costs. We’re here to set the record straight about how these medicines are reshaping America’s health care landscape and improving patient and provider choice.
How a company aimed at bringing the woolly mammoth back to life spun off a startup that could speed drug development
PharmaVoice
OCTOBER 20, 2022
Colossal Biosciences announced the creation of Form Bio — and its “operating system for science” — in September.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Therapies Targeting Capsid Proteins Show Promise for HIV-1
Pharmacy Times
OCTOBER 19, 2022
By targeting the viral conical core, these ARTs could disrupt the process of assembly and/or disassembly of the virus and result in its suppression.
Impact of the SARS-CoV-2 Omicron Variant on COVID-19 Reinfection Rates
Drug Topics
OCTOBER 21, 2022
The Omicron variant radically changed reinfection rates.
CVS Health supports future of pharmacy through minority scholarship program
Drug Store News
OCTOBER 19, 2022
The scholarships represent a commitment to an inclusive community and promoting diversity of thought, background, perspective and experience to advance pharmacy education and improve patient health.
Woman of the Week: Exscientia’s Charlotte Deane
PharmaVoice
OCTOBER 19, 2022
Is the industry ready for a biologic discovery revolution? Charlotte Deane, chief scientist of biologics AI at Exscientia, thinks so.
Boston University researchers’ testing of lab-made version of Covid virus draws government scrutiny
STAT
OCTOBER 17, 2022
Research at Boston University that involved testing a lab-made hybrid version of the SARS-CoV-2 virus is garnering heated headlines alleging the scientists involved could have unleashed a new pathogen. There is no evidence the work, performed under biosecurity level 3 precautions in BU’s National Emerging Infectious Diseases Laboratories, was conducted improperly or unsafely.
Poor Sleep in Premenopausal and Perimenopausal Women Linked to Migraine History
Drug Topics
OCTOBER 18, 2022
History of migraine may be associated with poor sleep in premenopausal and perimenopausal women, according to research presented at the North American Menopause Society Annual Meeting.
Cod Liver Oil Supplementation Not Found to Impact COVID-19 Prevention
Pharmacy Times
OCTOBER 20, 2022
Study finds daily supplementation with cod liver oil for 6 months during the SARS-CoV-2 pandemic did not reduce the incidence of SARS-CoV-2 infection.
Think your company could be on HHS’ drug price negotiation list? Here’s how to navigate next steps
PharmaVoice
OCTOBER 18, 2022
Know what to expect from the CMS over the next few months as it implements the drug reforms laid out in the Inflation Reduction Act.
Thérèse Coffey criticised for giving leftover antibiotics to a friend
The Guardian - Pharmaceutical Industry
OCTOBER 16, 2022
Health secretary accused of ‘monumental stupidity’ for saying she had shared a prescribed medication Doctors have rounded on the health secretary, Thérèse Coffey, after she admitted to sharing prescription medicines with others, actions the British Medical Association described as both dangerous and against the law. Coffey told civil servants in a meeting last month that she had given leftover antibiotics to a poorly friend, an admission that came as the discussion on how to alleviate pressures
Earlier Intervention Can Decrease Hospitalizations for COVID-19
Drug Topics
OCTOBER 19, 2022
Implementing mask mandates even days earlier can cause a decrease in the number of cumulative hospitalizations due to COVID-19.
Tackling immune-mediated disease with CAR Tregs
European Pharmaceutical Review
OCTOBER 20, 2022
In recent years there has been significant development within the cell therapy field, as chimeric antigen receptor (CAR) T-cell therapy demonstrated an ability to transform the treatment of patients with haematological malignancies. Recognising the potential of CAR T cells to act as highly targeted therapeutics, several biotechnology companies – including Sangamo Therapeutics – have established development pipelines of CAR T regulatory cells (Tregs) that aim to tackle immune?
He helped discover BMS’s psoriasis pill Sotyktu. Here’s what he has to say about early science in Big Pharma
PharmaVoice
OCTOBER 17, 2022
Bristol Myers Squibb’s senior principal scientist Ryan Moslin shares why his team was built for success and how they ushered a potential psoriasis blockbuster through discovery.
CDC: Signs point to an early start for flu season, with cases already ticking up in parts of the U.S.
STAT
OCTOBER 17, 2022
Before the Covid-19 pandemic emerged, influenza trackers would begin reading tea leaves around this time of the year, looking for signs of whether there would be an early start to the flu season in the northern hemisphere and which of the various flu viruses might be responsible for the most cases over the coming winter. Flu transmission has been low since the start of the pandemic , but an odd spurt of activity in April, May, and even early June of 2022 — which coincided with the onset o
Increased HPV Knowledge Could Lead to Increased Vaccination Rates
Drug Topics
OCTOBER 19, 2022
Improving vaccination rates for the most common STI in the United States could be as simple as increasing knowledge about HPV.
Study: PrEP Does Not Cause Shift in Vaginal Microbial Communities
Pharmacy Times
OCTOBER 21, 2022
Investigators examined the impact of daily oral tenofovir disoproxil fumarate in combination with emtricitabine to see the effect on the microbiota in South African women.
Let's personalize your content